1. The role of brain magnetic resonance imaging on the timing of antiepileptic drugs withdrawal following mesial temporal lobe epilepsy surgery
- Author
-
F. Babtain, Baeesa Saleh, Alqadi Khalid, Al Said Youssef, and Miad Albalawi
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Electroencephalography ,Hippocampus ,medicine ,Humans ,Anterior temporal lobectomy ,Retrospective Studies ,Hippocampal sclerosis ,medicine.diagnostic_test ,business.industry ,Brain ,Magnetic resonance imaging ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,Discontinuation ,Psychiatry and Mental health ,Treatment Outcome ,Epilepsy, Temporal Lobe ,Anticonvulsants ,Histopathology ,Neurology (clinical) ,Abnormality ,business ,Mesial temporal lobe epilepsy - Abstract
OBJECTIVES To assess the influence of magnetic resonance imaging (MRI) brain findings on the timing of antiepileptic drugs (AEDs) withdrawal following anterior temporal lobectomy (ATL) in patients with mesial temporal lobe epilepsy (MTLE). METHODS We conducted a retrospective chart review at King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia from Jan, 2004 - Dec, 2017 of patients with MTLE who underwent ATL and included patients who had a minimum of 2 years of follow-up. We evaluated the association between the time required to start tapering and discontinuing AEDs after ATL in patients with Engel class I outcomes and their preoperative brain MRI. RESULTS We studied 64 patients who underwent ATL. The majority of patients (63%) had hippocampal sclerosis (HS) on histopathology. Following ATL, the mean time to start tapering AEDs was 10 months and AEDs were discontinued at a mean of 48 months. Abnormal brain MRI was observed in 53 (83%) patients, with findings suggestive of mesial temporal sclerosis (MTS) accounting for 75% of these abnormalities. The presence of any MRI abnormality was associated with a 10-month earlier tapering of AEDs (p
- Published
- 2021